Contents
Current Drug Safety, Volume 11 - Number 1
Preface
Editorial
Biologic Therapy in Psoriasis: Safety Profile
, 11(1): 4 - 11Anna Campanati, Giulia Ganzetti, K. Giuliodori, Elisa Molinelli and A. Offidani
DOI: 10.2174/1574886310666151014115532
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
, 11(1): 12 - 21Giulia Ganzetti, Anna Campanati, E. Molinelli and A. Offidani
DOI: 10.2174/1574886310666151014121732
Biologic Therapy in Inflammatory and Immunomediated Arthritis: Safety Profile
, 11(1): 22 - 34Michele Maria Luchetti, Andrea Balloni and Armando Gabrielli
DOI: 10.2174/1574886310666151014115401
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
, 11(1): 35 - 43E. Molinelli, A. Campanati, G. Ganzetti and A. Offidani
DOI: 10.2174/1574886310666151014115127
Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile
, 11(1): 44 - 46Gianluca Moroncini, Lisa Albani, Lorenzo Nobili and Armando Gabrielli
DOI: 10.2174/1574886310666151014115251
Biologic Therapy in Inflammatory Eye Conditions (Ophtalmology): Safety Profile
, 11(1): 47 - 54Piergiorgio Neri, Ilir Arapi, Michele Nicolai, Vittorio Pirani, Andrea Saitta, Michele M. Luchetti, Alfonso Giovannini and Cesare Mariotti
DOI: 10.2174/1574886310666151014114925
Biologic Drugs in Crohn's Disease and Ulcerative Colitis: Safety Profile
, 11(1): 55 - 61Antonio Di Sario, Emanuele Bendia, Laura Schiadà, Paola Sassaroli and Antonio Benedetti
DOI: 10.2174/157488631101160212171757
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
, 11(1): 62 - 68Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli
DOI: 10.2174/1574886311207040289
Evidence of Stability of Medicines Repackaged in Compliance Aids: A Review
, 11(1): 69 - 77Alison Haywood and Beverley D. Glass
DOI: 10.2174/1574886310666150928104931
Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis
, 11(1): 78 - 85Aaron D. Drovandi, Carla C. Chen and Beverley D. Glass
DOI: 10.2174/1574886311207040282
Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis
Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
, 11(1): 86 - 98Guillermo A. Keller, Paulino A. Alvarez, Marcelo L. Ponte, Waldo H. Belloso, Claudia Bagnes, Cecilia Sparanochia, Claudio D. Gonzalez, M. Cecilia Villa Etchegoyen, Roberto A. Diez and Guillermo Di Girolamo
DOI: 10.2174/1574886311207040262
A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child
, 11(1): 99 - 101María Á. Pena, Sonia Pérez, Mª Concepción Zazo, Pedro J. Alcalá, Juan D. Cuello, Pedro Zapater and Roberto Reig
DOI: 10.2174/1574886310666150921103852
Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company
, 11(1): 104 - 108Luca Gallelli, Giuseppe Gallelli, Giuseppe Codamo, Angela Argentieri, Andzelika Michniewicz, Antonio Siniscalchi, Roberta Stefanelli, Erika Cione, Maria C. Caroleo, Paola Longo and Giovambattista De Sarro
DOI: 10.2174/1574886311207040309
Erratum
Webmaster Contact: info@benthamscience.net